Phenotypic analysis of 1-B-d-arabinofuranosylcytosine deamination in patients treated with high doses and correlation with response
- 1 January 1992
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 30 (2), 126-130
- https://doi.org/10.1007/bf00686404
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Pharmacokinetics of ara-C and ara-U in plasma and CSF after high-dose administration of cytosine arabinosideCancer Chemotherapy and Pharmacology, 1992
- Genetic Polymorphisms of Drug MetabolismPublished by Elsevier ,1990
- Effect of uracil arabinoside on metabolism and cytotoxicity of cytosine arabinoside in L5178Y murine leukemia.JCI Insight, 1985
- The use of intermediate dose cytosine arabinoside (ID Ara‐C) in the treatment of acute non‐lymphocytic leukaemia in relapseBritish Journal of Haematology, 1984
- The relationship of Ara-C metabolism in vitro to therapeutic response in acute myeloid leukaemiaCancer Chemotherapy and Pharmacology, 1982
- Relationship between plasma Ara-C and intracellular Ara-CTP pools under conditions of continuous infusion and high-dose Ara-C treatmentMedical and Pediatric Oncology, 1982
- Detection after electrophoresis of enzymes involved in ammonia metabolism using L-glutamate dehydrogenase as a linking enzymeBiochemical Genetics, 1977
- STUDIES ON MECHANISMS OF RESISTANCE TO CYTOSINE ARABINOSIDE: PROBLEMS IN THE DETERMINATION OF RELATED ENZYME ACTIVITIES IN LEUKEMIC CELLSAnnals of the New York Academy of Sciences, 1975
- Transport of two non-metabolized nucleosides, deoxycytidine and cytosine arabinoside, in a sub-line of the L1210 murine leukemiaBiochimica et Biophysica Acta (BBA) - Biomembranes, 1968
- Studies of the enzymatic deamination of cytosine arabinoside—IBiochemical Pharmacology, 1965